News
tebu-bio has developed a protein expression platform in CHO cells that allows transient protein expression and selection of CHO cell lines stably expressing recombinant proteins in suspension ...
21h
TipRanks on MSNCircio Holding ASA Releases 2024 Annual ReportTargovax ASA ( ($GB:0RIS) ) just unveiled an update. Circio Holding ASA’s Board of Directors has approved the company’s 2024 Annual Report, which ...
ProteinChip technology incorporates surface-enhanced laser desorption/ionization with mass spectrometry to allow for the rapid profiling and comparison of protein expression in normal and diseased ...
- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the ...
Sino Biological has fixed an in vitro efficacy evaluation platform. Furthermore, the company offers high-quality cytokines and protein expression services for cell proliferation inhibition assays ...
Sponsored content brought to you by The advent of multiomic approaches has significantly improved early cancer detection by ...
Based on the thorough experience and expertise in recombinant production, Sino Biological delivers high-purity and high-activity proteins with the baculovirus–insect cell protein expression platform.
Islet cells cultured within the HICA-V platform demonstrated increased insulin production and binding protein expression, exhibiting functional characteristics comparable to native islets.
A team recently detailed an auto-expression medium to maximize protein production that uses galactose rather than lactose to induce auto-expression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results